| Single-dose oral ivermectin in mild and moderate COVID-19 (RIVET-COV): A single-centre randomized, placebo-controlled trial A Mohan, P Tiwari, TM Suri, S Mittal, A Patel, A Jain, T Velpandian, ... Journal of Infection and Chemotherapy 27 (12), 1743-1749, 2021 | 91* | 2021 |
| Development and validation of stability indicating method for estimation of buparvaquone by forced degradation studies S Tanveer, S Sushil, K Lalatsa, K Rajendra Indian Journal of Pharmaceutical Education and Research 54 (3), 790-797, 2020 | 1 | 2020 |
| Telehealth of cardiac devices for CVD treatment S Shelke, K Veerubhotla, Y Lee, CH Lee Biotechnology and Bioengineering 121 (3), 823-834, 2024 | | 2024 |
| Development and validation of novel ultraviolet spectrophotometric method for estimation of antileishmanial drug buparvaquone TK Shaikh, SS Shelke, IR Kakde, A Lalatsa, RB Kakde Indian Journal of Pharmaceutical Sciences 84 (1), 130-136, 2022 | | 2022 |
